CI

The Cigna Group

CIHealthcareNASDAQ

Healthcare Plans · Last scanned Oct 24, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$273.85B
+11.3% YoY
Net Income
$5.96B
+73.5% YoY
EBITDA
$11.96B
+26.2% YoY
Free Cash Flow
$7.98B

Scan Results

Daily timeframe
8 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20CONFIRMED▼ RSI OverboughtRSI 74.7, above 70, stock may be overbought
Oct 19CONFIRMED▼ RSI OverboughtRSI 82.6, above 70, stock may be overbought
About The Cigna Group

Headquartered within the healthcare sector, The Cigna Group focuses on Healthcare Plans services and products. The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. At a $81.11B market cap, The Cigna Group ranks as a large-cap company within healthcare. It operates through two segments: Evernorth Health Services and Cigna Healthcare.

Where CI stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, CI finished 6.94% above its 150-day moving average ($279.13) and 7.35% above its 200-day moving average ($278.07). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CI overbought or oversold?

At the October 20, 2026 close, CI's RSI(14) was 74.7, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$81.11B
P/E (TTM)12.69
Fwd P/E9.17
EPS$24.19
Beta0.30
52W Change+1.7%
Dividend Yield2.03%
ROE16.8%
Analysis

On the balance sheet, CI has $7.26B in cash with $31.88B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $7.98B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 16.8% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $179.36B (2022) to $273.85B (2025), reflecting a 53% increase over the period.

The relatively low beta of 0.30 suggests CI is a less volatile holding compared to the broader index. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence The Cigna Group's trajectory.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms